See more : Bitcoin Group SE (0RWM.L) Income Statement Analysis – Financial Results
Complete financial analysis of Aion Therapeutic Inc. (AION.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aion Therapeutic Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Costar Group Co., Ltd. (002189.SZ) Income Statement Analysis – Financial Results
- RMG Acquisition Corporation II (RMGBU) Income Statement Analysis – Financial Results
- Sonendo, Inc. (SONX) Income Statement Analysis – Financial Results
- Amit International Limited (AMITINT.BO) Income Statement Analysis – Financial Results
- MCAN Mortgage Corporation (MAMTF) Income Statement Analysis – Financial Results
Aion Therapeutic Inc. (AION.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.aiontherapeutic.com/
About Aion Therapeutic Inc.
Aion Therapeutic Inc. offer medical cannabis products in Canada. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was incorporated in 2011 and is headquartered in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 367.48K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 204.36K | 17.30K | 65.29K | 1.50 | 111.05K | 0.00 | 2.00K | 0.00 |
| Gross Profit | 163.12K | -17.30K | -65.29K | -1.50 | -111.05K | 0.00 | -2.00K | 0.00 |
| Gross Profit Ratio | 44.39% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 953.00K | 0.00 | 18.40K | 15.99K | 306.76K | 0.00 |
| General & Administrative | 967.81K | 587.83K | 1.80M | 2.65M | 851.16K | 1.68M | 184.71K | 109.07K |
| Selling & Marketing | 53.58K | 0.00 | 0.00 | 0.00 | 2.03K | 7.41K | 22.72K | 16.51K |
| SG&A | 1.02M | 587.83K | 1.80M | 2.65M | 853.19K | 1.68M | 207.43K | 125.58K |
| Other Expenses | -858.27K | 0.00 | 65.29K | 128.13K | 0.00 | -34.04K | 76.35K | 3.66K |
| Operating Expenses | 163.12K | 975.70K | 2.82M | 2.78M | 982.64K | 1.70M | 207.43K | 125.58K |
| Cost & Expenses | 1.56M | 975.70K | 2.82M | 2.78M | 982.64K | 1.70M | 207.43K | 125.58K |
| Interest Income | 14.99K | 149.84 | 75.72 | 186.07 | 321.19 | 679.12 | 0.00 | 0.00 |
| Interest Expense | 171.39K | 149.84K | 75.72K | 186.07K | 321.19K | 679.12K | 9.04K | 11.37K |
| Depreciation & Amortization | 42.11K | 17.30K | 65.29K | 128.13K | 111.05K | 1.49M | 2.53M | 3.66K |
| EBITDA | -6.07M | -89.52K | -3.68M | -7.95M | -240.59K | -3.44M | -131.08K | -121.92K |
| EBITDA Ratio | -1,652.80% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.19M | -1.08M | -2.39K | -2.60K | -996.64K | -1.70M | -207.43K | -125.58K |
| Operating Income Ratio | -324.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -5.10M | 602.98K | -999.48K | -5.66M | 323.81K | -3.23M | 69.31K | -1.38M |
| Income Before Tax | -6.29M | -256.66K | -3.82M | -8.27M | -672.83K | -4.93M | -140.11K | -1.51M |
| Income Before Tax Ratio | -1,710.90% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 41.03K | 75.72K | 186.07K | 321.19K | 679.12K | 9.04K | 11.37K |
| Net Income | -6.29M | -256.66K | -3.82M | -8.27M | -672.83K | -5.61M | -140.11K | -1.51M |
| Net Income Ratio | -1,710.90% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.02 | 0.00 | -0.03 | -0.09 | -0.02 | -0.20 | 0.00 | -0.04 |
| EPS Diluted | -0.02 | 0.00 | -0.03 | -0.09 | -0.02 | -0.20 | 0.00 | -0.04 |
| Weighted Avg Shares Out | 265.07M | 146.40M | 139.89M | 93.90M | 35.89M | 27.48M | 34.67M | 34.67M |
| Weighted Avg Shares Out (Dil) | 265.07M | 146.40M | 139.89M | 93.90M | 35.89M | 27.48M | 34.67M | 34.67M |
Source: https://incomestatements.info
Category: Stock Reports